Allergies News and Research

Latest Allergies News and Research

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

Scientists isolated a molecule, extracted from the leaves of the European chestnut tree, with the power to neutralize dangerous, drug-resistant staph bacteria. Frontiers in Pharmacology published the finding, led by scientists at Emory University.

28 Jun 2021

UNC study provides important information for developing a viable vaccine against dengue

Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or serotypes. Unless a vaccine protects against all four, a vaccine can wind up doing more harm than good.

25 Jun 2021

Study examines safety of COVID-19 vaccination during lactation

A new preprint, recently released on the medRxiv* server, reports from real life in a cohort of mother-child dyads in Singapore. The mothers were lactating after having received COVID-19 vaccination.

25 Jun 2021

Is COVID-19 more severe in pregnancy?

A new study, released as a preprint on the medRxiv* server, indicates that pregnant women are more likely to develop severe disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

24 Jun 2021

COVID-19 prevalence in the U.S. has far exceeded the known number of cases

In a new study, National Institutes of Health researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

24 Jun 2021

Internal communication network in mammals provides new insights on obesity, skin disorders

National Institutes of Health scientists and their collaborators have identified an internal communication network in mammals that may regulate tissue repair and inflammation, providing new insights on how diseases such as obesity and inflammatory skin disorders develop. The new research is published in Cell.

24 Jun 2021

New class of compounds can stop the reproduction of coronavirus

A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread also makes it vulnerable to a new class of drug candidates, a new study finds.

24 Jun 2021

NIH begins study to evaluate how pregnant, postpartum people react to COVID-19 vaccines

A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people.

23 Jun 2021

Airborne pollen grains facilitate spread of COVID-19 by carrying SARS-CoV-2 particles

Computer models simulating the movement of pollen grains from trees in crowded areas could accelerate the spread of COVID-19.

23 Jun 2021

New study enrolls young adults to evaluate SARS-CoV-2 infection

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

23 Jun 2021

Researchers investigate how pollen facilitates the spread of COVID-19 virus

Most models explaining how viruses are transmitted focus on viral particles escaping one person to infect a nearby person. A study on the role of microscopic particles in how viruses are transmitted suggests pollen is nothing to sneeze at.

22 Jun 2021

New universal vaccine protects mice against COVID-19 and other coronaviruses

Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine that protected mice not just against COVID-19 but also other coronaviruses and triggered the immune system to fight off a dangerous variant.

22 Jun 2021

Engineering nanobodies to fight against the SARS-CoV-2 virus

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

22 Jun 2021

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

All coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-based SARS-CoV-2 research has focused on the spike and nucleocapsid proteins.

22 Jun 2021

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Scientists have a general idea of how viruses invade and spread in the body, but the precise mechanisms are actually not well understood, especially when it comes to Ebola virus.

18 Jun 2021

Previous SARS-CoV-2 infection, vaccines provide protection against gamma variant, study finds

In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.

18 Jun 2021

FDA approves antihistamine nasal spray for over-the-counter use

The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.

17 Jun 2021

Antibody combination REGEN-COV prevents symptomatic disease following SARS-CoV-2 infection

Researchers in the United States have demonstrated the effectiveness of early treatment with REGEN-COV™ at preventing symptomatic disease among people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

17 Jun 2021

Researchers prepare for next coronavirus pandemic

Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year pattern since 2004.

17 Jun 2021

New study may lead to more effective and powerful COVID-19 vaccines

A new study looking at the way human cells activate the immune system in response to SARS-CoV-2 infection could open the door to even more effective and powerful vaccines against the coronavirus and its rapidly emerging variants keeping the global pandemic smoldering.

17 Jun 2021

Allergies News and Research

Latest Allergies News and Research

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

UNC study provides important information for developing a viable vaccine against dengue

Study examines safety of COVID-19 vaccination during lactation

Is COVID-19 more severe in pregnancy?

COVID-19 prevalence in the U.S. has far exceeded the known number of cases

Internal communication network in mammals provides new insights on obesity, skin disorders

New class of compounds can stop the reproduction of coronavirus

NIH begins study to evaluate how pregnant, postpartum people react to COVID-19 vaccines

Airborne pollen grains facilitate spread of COVID-19 by carrying SARS-CoV-2 particles

New study enrolls young adults to evaluate SARS-CoV-2 infection

Researchers investigate how pollen facilitates the spread of COVID-19 virus

New universal vaccine protects mice against COVID-19 and other coronaviruses

Engineering nanobodies to fight against the SARS-CoV-2 virus

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Previous SARS-CoV-2 infection, vaccines provide protection against gamma variant, study finds

FDA approves antihistamine nasal spray for over-the-counter use

Antibody combination REGEN-COV prevents symptomatic disease following SARS-CoV-2 infection

Researchers prepare for next coronavirus pandemic

New study may lead to more effective and powerful COVID-19 vaccines

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in